A ... of myocardial injury markers
For emergency department patients with suspected myocardial infarction chest discomfort, current clinical symptomatic myocardial injury, combined ECG and blood biomarkers such as creatine kinase (CK), MB isoenzyme of creatine kinase (CK-MB), Myoglobin (Mb/Myo) and cardiac troponin I (cardiacTrop onin,cTn) I or t for diagnosis and differential diagnosis. Under normal circumstances, these markers in myocardial cells, are released into the blood after the attack of myocardial infarction, found elevated levels of these substances in the blood indicates that the presence of myocardial injury.
B. understanding cardiac markers
Natriuretic peptide, also known as b-type natriuretic peptide (BNP) is important for regulation of body fluid and sodium balance, blood pressure hormones, when blood volume increases and massive secretion of left ventricular pressure overload, detection of BNP or NT-proBNP can help establish the diagnosis of congestive heart failure.
C. predicting heart risk marker for events
Clinical determination of serum total cholesterol (TC) and LDL-cholesterol (LDL-c, also known as "bad cholesterol"), high-density lipoprotein cholesterol (HDL-c, also known as "good cholesterol") and triglycerides (TG), and serum lipoprotein and apolipoprotein AI and b (a), such as project level risk assessment of cardiac events are very important.
C-reactive protein (CRP) is an inflammatory biomarker, elevated CRP in patients, the increased risk of heart attack, sudden death and blood vessel diseases.
Besides determination of lipoprotein phospholipase A2 (LP-PLA2) whether elevated levels can indicate arterial plaque formation and rupture of any risk.